Open Access Open Access  Restricted Access Subscription or Fee Access

Clinical View of Carcinoma

Gyanendra kumar Gupta, Gagan Devi

Abstract


Cancer describes a large group of diseases, which have one common thing i.e., cells that are growing out of control. Cells that make up all parts of our body go through a predictable life cycles-old cells die, and new cells arrives to take their place, this occurs in physiology of our body. This process goes away, and cells begin to multiply out of control. The end result is the mass of cells called a Tumour i.e. a Pathological state.


Keywords


Cancer, Disease, Physiology, Tumor and Pathological state

Full Text:

PDF

References


Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19; 294(8): 405-10.

Li MC, Hertz R, Bergenstal DM. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med. 1958 Jul 10; 259(2): 66-74.

Jaffe N, Link MP, Cohen D, Traggis D, Frei E 3rd, Watts H, Beardsley GP, Abelson HT. High-dose methotrexate in osteogenic sarcoma. Natl Cancer Inst Monogr 1981 Apr; (56): 201-6.

Corbin AS, Buchdunger E, Pascal F, Druker BJ. Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. J Biol Chem 2002 Aug 30; 277(35): 32214-9.

O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ. Imatinib compared with interferon and lowdose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003 Mar 13; 348(11): 994-1004.

Abeloff: Clinical Oncology, 3rd ed. Churchill Livingston, 2004. Pp 408-413.

Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT. Nitrogen mustard therapy. Use of methyl-bis(betachloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. J Am Med Assoc. 1946 Sep 21; 132(2): 126-32.

Gilman A. The initial clinical trial of nitrogen mustard. Am J Surg. 1963 May; 105(5), 4-8

Gilman A. The biological actions and therapeutic applications of the Bchloroethyl amines and sulfides. Science 1946 Apr 5; 103(2675):409-36.

Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA. Temporary remissions in acute leukemia in children produced by folic antagonist, 4aminopteroylglutamic acid (aminopterin). N Engl J Med 1948 Jun 3; 238(23):787-93.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Research & Reviews: Journal of Oncology and Hematology